INTELLIGENT BIO SOLUTIONS INC. Inventory, Finished Goods, Gross
INTELLIGENT BIO SOLUTIONS INC. (INBS) had Inventory, Finished Goods, Gross of $152.52 thousand as of 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryFinishedGoods · last filed 2026-08-19
- 2026-06-30: Inventory, Finished Goods, Gross $152.52K.
- 2026-03-31: Inventory, Finished Goods, Gross $293.98K.
- 2025-12-31: Inventory, Finished Goods, Gross $265.88K.
- 2025-09-30: Inventory, Finished Goods, Gross $333.14K.
| Period end | Inventory, Finished Goods, Gross |
|---|---|
| 2026-06-30 | $152.52K 10-K · filed 2026-08-19 |
| 2026-03-31 | $293.98K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $265.88K 10-Q · filed 2026-02-12 |
| 2025-09-30 | $333.14K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $430.13K 10-K · filed 2026-08-19 |
| 2025-03-31 | $409.94K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $449.13K 10-Q · filed 2025-02-13 |
| 2024-09-30 | $519.74K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $588.84K 10-K · filed 2025-08-15 |
| 2024-03-31 | $518.47K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $1.21M 10-Q · filed 2024-02-09 |
| 2023-09-30 | $1.22M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $757.52K 10-K · filed 2024-09-18 |
| 2023-03-31 | $378.17K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $215.60K 10-Q · filed 2023-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |